The effect of Huo-Long Cupping therapy on cancerous abdominal distension

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300069603

Enrollment

Unknown

Registered

2023-03-21

Start date

2023-03-31

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer

Interventions

conrol group :conventional treatment and care

intervention group :Huo-Long Cupping therapy, and conventional treatment and care

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Pathological diagnosis was malignant tumor complicated with cancerous abdominal distension; 2. 18~85 years old; 3. Predicted survival > 12 weeks; 4. Voluntary participation in the study.

Exclusion criteria

Exclusion criteria: 1. Patients with abdominal skin damage or ulceration; 2. Patients with intestinal obstruction requiring surgical treatment; 3. Patients with severe primary disease of the heart, kidney, lung, endocrine, blood, metabolism, and gastrointestinal tract; 4. Patients who have suffered from mental illness or are receiving treatment for mental illness; 5. Pregnant or lactating women; 6. Patients who are receiving other research interventions to relieve abdominal cancer distension.

Design outcomes

Primary

Measure	Time frame
Abdominal distension;	—

Secondary

Measure	Time frame
burden of symptoms;Quality of life;	—

Countries

China

Contacts

Public ContactYe Hong

Guangdong Provincal Hospital of Chinese Medicine

42068691@qq.com13533935792

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026